Nordness Mark E, Lynn John, Zacharisen Michael C, Scott Paul J, Kelly Kevin J
Department of Pediatrics, Children's Research Institute, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Clin Mol Allergy. 2005 Jan 21;3(1):2. doi: 10.1186/1476-7961-3-2.
BACKGROUND: Asthma and sickle cell disease are common conditions that both may result in pulmonary complications. We hypothesized that children with sickle cell disease with concomitant asthma have an increased incidence of vaso-occlusive crises that are complicated by episodes of acute chest syndrome. METHODS: A 5-year retrospective chart analysis was performed investigating 48 children ages 3-18 years with asthma and sickle cell disease and 48 children with sickle cell disease alone. Children were matched for age, gender, and type of sickle cell defect. Hospital admissions were recorded for acute chest syndrome, cerebral vascular accident, vaso-occlusive pain crises, and blood transfusions (total, exchange and chronic). Mann-Whitney test and Chi square analysis were used to assess differences between the groups. RESULTS: Children with sickle cell disease and asthma had significantly more episodes of acute chest syndrome (p = 0.03) and cerebral vascular accidents (p = 0.05) compared to children with sickle cell disease without asthma. As expected, these children received more total blood transfusions (p = 0.01) and chronic transfusions (p = 0.04). Admissions for vasoocclusive pain crises and exchange transfusions were not statistically different between cases and controls. SS disease is more severe than SC disease. CONCLUSIONS: Children with concomitant asthma and sickle cell disease have increased episodes of acute chest syndrome, cerebral vascular accidents and the need for blood transfusions. Whether aggressive asthma therapy can reduce these complications in this subset of children is unknown and requires further studies.
背景:哮喘和镰状细胞病是常见病症,两者都可能导致肺部并发症。我们推测,患有镰状细胞病且伴有哮喘的儿童发生血管闭塞性危象并伴有急性胸综合征发作的几率会增加。方法:进行了一项为期5年的回顾性图表分析,调查了48名3至18岁患有哮喘和镰状细胞病的儿童以及48名仅患有镰状细胞病的儿童。根据年龄、性别和镰状细胞缺陷类型对儿童进行匹配。记录因急性胸综合征、脑血管意外、血管闭塞性疼痛危象和输血(总量、置换和长期)而住院的情况。采用曼-惠特尼检验和卡方分析来评估两组之间的差异。结果:与不伴有哮喘的镰状细胞病儿童相比,患有镰状细胞病和哮喘的儿童急性胸综合征发作次数(p = 0.03)和脑血管意外次数(p = 0.05)明显更多。正如预期的那样,这些儿童接受的全血输血总量(p = 0.01)和长期输血(p = 0.04)更多。血管闭塞性疼痛危象和置换输血的住院情况在病例组和对照组之间无统计学差异。SS病比SC病更严重。结论:患有哮喘和镰状细胞病的儿童急性胸综合征发作次数、脑血管意外次数增加,且需要输血。积极的哮喘治疗能否减少这部分儿童的这些并发症尚不清楚,需要进一步研究。
Cochrane Database Syst Rev. 2014-1-8
Cochrane Database Syst Rev. 2011-9-7
Pediatr Allergy Immunol Pulmonol. 2017-12-1
Cochrane Database Syst Rev. 2016-8-30
Hematol Oncol Clin North Am. 2022-12
Cureus. 2022-8-29
Cochrane Database Syst Rev. 2019-9-18
Pediatr Allergy Immunol Pulmonol. 2017-12-1
Pediatr Allergy Immunol Pulmonol. 2017-12-1
Med Princ Pract. 2017-11-28
Mediterr J Hematol Infect Dis. 2017-4-15
J Pediatr. 1999-10
J Pediatr. 1997-8
N Engl J Med. 1994-6-9